Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical Patients

This cohort study examines factors associated with hospital-associated venous thromboembolism and its incidence among hospitalized patients.

[1]  C. Russ,et al.  Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study , 2022, Journal of Thrombosis and Thrombolysis.

[2]  N. Roetker,et al.  Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study , 2022, Journal of thrombosis and haemostasis : JTH.

[3]  K. L. Soh,et al.  Risk of VTE associated with PORTs and PICCs in cancer patients: A systematic review and meta-analysis. , 2022, Thrombosis research.

[4]  A. Khorana,et al.  COVID‐19 and venous thromboembolism: A narrative review , 2022, Research and Practice in Thrombosis and Haemostasis.

[5]  T. N. Gautier,et al.  Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism , 2021, Thrombosis and Haemostasis.

[6]  Handong Ma,et al.  A novel hierarchical machine learning model for hospital-acquired venous thromboembolism risk assessment among multiple-departments , 2021, J. Biomed. Informatics.

[7]  S. Goodacre,et al.  Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review , 2021, BMJ Open.

[8]  I. Khawaja,et al.  Iron Deficiency Anemia as a Rare Risk Factor for Recurrent Pulmonary Embolism and Deep Vein Thrombosis , 2021, Cureus.

[9]  Q. Yuan,et al.  Risk factors for venous thromboembolism in patients with diabetes undergoing joint arthroplasty , 2020, BMC Musculoskeletal Disorders.

[10]  S. de Lusignan,et al.  Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[11]  A. Khorana,et al.  Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association. , 2020, Circulation.

[12]  Marc S. Williams,et al.  Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study. , 2020, Thrombosis Research.

[13]  Jennifer E. Moore,et al.  Agency for Healthcare Research and Quality , 2020, Definitions.

[14]  Marc S. Williams,et al.  Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study. , 2019, The American journal of medicine.

[15]  H. Eldeeb,et al.  Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study , 2019, Thrombosis Journal.

[16]  J. Gallacher,et al.  Cardiovascular Risk Factors Associated With Venous Thromboembolism , 2019, JAMA cardiology.

[17]  F. Dentali,et al.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. , 2018, Blood advances.

[18]  K. Khunti,et al.  Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence , 2018, Annals of medicine.

[19]  Joanne M. Stubbs,et al.  Incidence of in‐hospital and post‐discharge diagnosed hospital‐associated venous thromboembolism using linked administrative data , 2018, Internal medicine journal.

[20]  K. Ruskin.  Deep vein thrombosis and venous thromboembolism in trauma , 2018, Current opinion in anaesthesiology.

[21]  A. Auerbach,et al.  Automating Venous Thromboembolism Risk Calculation Using Electronic Health Record Data Upon Hospital Admission: The Automated Padua Prediction Score , 2017, Journal of hospital medicine.

[22]  S. Steinhubl,et al.  Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. , 2017, Medical care.

[23]  V. Chopra,et al.  Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients. , 2016, The American journal of medicine.

[24]  Teresa Y. Lin,et al.  The Kaiser Permanente Northern California Adult Member Health Survey. , 2016, The Permanente journal.

[25]  Herng‐Ching Lin,et al.  Association between venous thromboembolism and iron-deficiency anemia: a population-based study , 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[26]  Olga V. Patterson,et al.  Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010. , 2015, Thrombosis research.

[27]  K. Bailey,et al.  Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. , 2015, Surgery.

[28]  John A. Heit,et al.  The epidemiology of venous thromboembolism , 2003, Journal of Thrombosis and Thrombolysis.

[29]  G. Raskob,et al.  Thrombosis: a major contributor to the global disease burden , 2014, Journal of thrombosis and haemostasis : JTH.

[30]  G. Raskob,et al.  Thrombosis: A Major Contributor to Global Disease Burden , 2014, Seminars in Thrombosis & Hemostasis.

[31]  V. Chopra,et al.  Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study. , 2014, JAMA internal medicine.

[32]  C. Francis,et al.  Platelets and cancer-associated thrombosis. , 2014, Seminars in oncology.

[33]  E. Haut,et al.  Practices to prevent venous thromboembolism: a brief review , 2013, BMJ quality & safety.

[34]  Jeanette W. Chung,et al.  Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. , 2013, JAMA.

[35]  D. Bates,et al.  The global burden of unsafe medical care: analytic modelling of observational studies , 2013, BMJ quality & safety.

[36]  E. Masliah,et al.  Fatal pulmonary embolism update: 10 years of autopsy experience at an academic medical center , 2013, JRSM short reports.

[37]  Elie A Akl,et al.  Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[38]  Madison,et al.  Venous thromboembolism in adult hospitalizations - United States, 2007-2009. , 2012, MMWR. Morbidity and mortality weekly report.

[39]  F. Rosendaal,et al.  Risk assessment for recurrent venous thrombosis , 2010, The Lancet.

[40]  P. Prandoni,et al.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score , 2010, Journal of thrombosis and haemostasis : JTH.

[41]  H. Atrash,et al.  Prevalence of venous thromboembolism among privately insured US adults. , 2010, Archives of internal medicine.

[42]  Hans L Hillege,et al.  Microalbuminuria and risk of venous thromboembolism. , 2009, JAMA.

[43]  C. Keenan,et al.  Effects of race and ethnicity on the incidence of venous thromboembolism. , 2009, Thrombosis research.

[44]  Gabriel J. Escobar,et al.  Risk-Adjusting Hospital Inpatient Mortality Using Automated Inpatient, Outpatient, and Laboratory Databases , 2008, Medical care.

[45]  J. Heit.  Venous thromboembolism: disease burden, outcomes and risk factors , 2005, Journal of thrombosis and haemostasis : JTH.

[46]  E. Minar,et al.  The risk of recurrent venous thromboembolism in men and women. , 2004, The New England journal of medicine.

[47]  L. Melton,et al.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.

[48]  L. Melton,et al.  Incidence of venous thromboembolism in hospitalized patients vs community residents. , 2001, Mayo Clinic proceedings.